Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reverse Medical developed innovative interventional devices targeting acute ischemic stroke and other neurovascular conditions. Its ReStore™ Microcatheter received FDA conditional IDE approval in 2009 to begin a multicenter clinical study. The company held multiple patents around its technology platforms. No recent data on commercial launch or later-stage results are available, suggesting the company did not reach commercialization before becoming inactive or being acquired.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reverse Medical.